| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 86 |
| 1 | AFLIBERCEPT | 52 |
| 2 | BEVACIZUMAB | 52 |
| 3 | ADALIMUMAB | 37 |
| 4 | PREDNISOLONE | 34 |
| 5 | PREDNISOLONE ORAL | 34 |
| 6 | PREDNISOLONE ORAL SOLUTION | 34 |
| 7 | DEXAMETHASONE | 33 |
| 8 | ASPIRIN | 32 |
| 9 | ERGOCALCIFEROL | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRYPAN BLUE | 1 | 0.0217 |
| 1 | TROPICAMIDE | 13 | 0.0080 |
| 2 | TETRACAINE | 3 | 0.0076 |
| 3 | PROPARACAINE HYDROCHLORIDE | 3 | 0.0056 |
| 4 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 6 | 0.0055 |
| 5 | EPHEDRINE SULFATE | 1 | 0.0046 |
| 6 | LANOLIN, PETROLATUM | 1 | 0.0040 |
| 7 | LANOLIN AND PETROLATUM | 1 | 0.0038 |
| 8 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 9 | RANIBIZUMAB | 86 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 149 |
| 1 | Corticosteroid [EPC] | 105 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 32 |
| 4 | Provitamin D2 Compound [EPC] | 32 |
| 5 | Insulin Analog [EPC] | 30 |
| 6 | Benzodiazepine [EPC] | 26 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 26 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 25 |
| 9 | Prostaglandin Analog [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiseptic [EPC] | 11 | 0.0025 |
| 1 | alpha-1 Adrenergic Agonist [EPC] | 10 | 0.0023 |
| 2 | Provitamin D2 Compound [EPC] | 32 | 0.0011 |
| 3 | Photoenhancer [EPC] | 4 | 0.0010 |
| 4 | Anticholinergic [EPC] | 14 | 0.0009 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 149 | 0.0008 |
| 6 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 13 | 0.0006 |
| 8 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 9 | Endoglycosidase [EPC] | 1 | 0.0005 |